<DOC>
	<DOC>NCT02947815</DOC>
	<brief_summary>The purpose of this study is to evaluate the Efficacy and Safety of NABOTA in treatment of essential blepharospasm</brief_summary>
	<brief_title>Safety and Efficacy of NABOTA in Treatment of Essential Blepharospasm</brief_title>
	<detailed_description />
	<mesh_term>Blepharospasm</mesh_term>
	<mesh_term>Botulinum Toxins, Type A</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>Male of female of at least 18 years old Grade 2~4 in Scott's scale</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>